Phase I randomized, observer-blinded, placebo-controlled study of a SARS-CoV-2 mRNA vaccine...
Nature· 2 days agoAccess to vaccines against SARS-CoV-2 virus was limited in poor countries during the COVID-19 pandemic. Therefore, a low-cost mRNA vaccine ...
Compound from magnolia tree bark found to impede SARS-CoV-2 replication in certain cells
Phys.org· 6 days agoA compound called honokiol, which is found in the bark of multiple species of magnolia tree, inhibits replication of SARS-CoV-2 virus ...
Here’s what Pfizer and Moderna say is next for their Covid vaccines
CNBC· 6 days agoA pharmacist prepares to administer COVID-19 vaccine booster shots during an event hosted by the...
Results of Study on COVID-19 Vaccine Response in Hematopoietic Cell Transplant Patients Published in...
Morningstar· 4 days agoMINNEAPOLIS, May 24, 2023 (GLOBE NEWSWIRE) -- Results from a joint study between CIBMTR (Center for International Blood and Marrow Transplant Research)—a research collaboration between the National Marrow Donor Program® (NMDP)/Be The Match® and the
There Is No Evidence Strong Enough to End the Pandemic-Origins Debate
The Atlantic· 4 days agoMany scientists think the new virus spilled over directly from a wild animal, perhaps at a Chinese...
CHMP Adopts Positive Opinion to Extend the Use of Veklury® (Remdesivir) to Treat COVID-19 in People...
Morningstar· 2 days agoGilead Sciences, Inc. (Nasdaq: GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) granted a positive opinion for the ...
QIAGEN (QGEN) Expands Enzyme Offering to Aid Laboratory
Zacks via Yahoo Finance· 5 days agoQIAGEN is a one-stop shop for all research needs, including solutions for sample preparation,...
Immune cells targeting core protein of virus are important for early immune defense against COVID-19
Medical Xpress· 4 days agoDespite intensive research since the beginning of the pandemic, it is still unclear which components of the immune system are involved in the early control of virus replication in the respiratory ...
After Covid-19, can mRNA vaccines help with cancer as well?
Knowable Magazine via Yahoo News· 3 days agoThe pandemic put the technology, long in development, to the test. Here’s a look at the status of...
Pfizer's PAXLOVID™ Receives FDA Approval for Adult Patients at High Risk of Progression to Severe...
Benzinga· 3 days agoPfizer Inc. PFE announced today that the U.S. Food and Drug Administration (FDA) approved PAXLOVID™ (nirmatrelvir tablets and ritonavir tablets) for the treatment of mild-to-moderate COVID-19 ...
Yahoo Web Search
Trending Now
